Oncternal Therapeutics, Inc. (ONCT)

NASDAQ: ONCT · IEX Real-Time Price · USD

8.55

-0.02 (-0.18%)

At close: Apr 24, 2024, 4:00 PM

8.60

+0.05 (0.64%)

Pre-market: Apr 25, 2024, 7:41 AM EDT

Oncternal Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2000
Revenue	0.79	1.49	4.32	3.38	2.43	2.52	0	0	0	0	Upgrade
Revenue Growth (YoY)	-47.32%	-65.47%	27.85%	39.18%	-3.81%	-	-	-	-	-	Upgrade
Gross Profit	0.79	1.49	4.32	3.38	2.43	2.52	0	0	0	0	Upgrade
Selling, General & Admin	12.75	13.46	11.6	8.37	7.29	1.82	9.19	8.71	8.23	9.48	Upgrade
Research & Development	29.75	32.98	24.09	12.54	10.16	8.29	21.47	17.23	13.61	20.87	Upgrade
Other Operating Expenses	0	0	0	0	18.09	0	0	0	0	0	Upgrade
Operating Expenses	42.5	46.44	35.68	20.92	35.53	10.11	30.66	25.93	21.84	30.35	Upgrade
Operating Income	-41.71	-44.95	-31.37	-17.54	-33.11	-7.59	-30.66	-25.93	-21.84	-30.35	Upgrade
Interest Expense / Income	0	0	0	0	0	0	0	0	0	0	Upgrade
Other Expense / Income	-2.24	-0.78	-0.03	-0.32	1.08	-1.01	-0.22	-8.21	-3.14	9.06	Upgrade
Pretax Income	-39.48	-44.17	-31.33	-17.23	-34.19	-6.58	-30.44	-17.72	-18.7	-39.41	Upgrade
Net Income	-39.48	-44.17	-31.33	-17.23	-34.19	-6.58	-30.44	-17.72	-18.7	-39.41	Upgrade
Shares Outstanding (Basic)	3	3	2	1	1	0	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	3	3	2	1	1	0	0	0	0	0	Upgrade
Shares Change	11.79%	6.65%	142.90%	96.58%	187.64%	44.12%	19.79%	-1.47%	80.64%	29.74%	Upgrade
EPS (Basic)	-13.43	-16.80	-12.80	-17.00	-66.20	-36.60	-245.00	-170.80	-186.20	-674.80	Upgrade
EPS (Diluted)	-13.43	-16.80	-12.80	-17.00	-66.20	-36.60	-245.00	-170.80	-205.80	-674.80	Upgrade
Free Cash Flow	-32.16	-36.7	-26.59	-17.5	-16.75	-7.42	-23.46	-20.87	-20.04	-28.76	Upgrade
Free Cash Flow Per Share	-10.94	-13.96	-10.78	-17.23	-32.42	-41.31	-188.33	-200.66	-199.87	-492.25	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	-	-	-	-	Upgrade
Operating Margin	-5313.89%	-3016.58%	-726.91%	-519.76%	-1365.28%	-300.91%	-	-	-	-	Upgrade
Profit Margin	-5029.17%	-2964.43%	-726.14%	-510.37%	-1409.81%	-260.97%	-	-	-	-	Upgrade
Free Cash Flow Margin	-4097.32%	-2463.36%	-616.20%	-518.37%	-690.56%	-294.21%	-	-	-	-	Upgrade
EBITDA	-39.31	-43.99	-31.16	-17.08	-34.1	-6.58	-30.39	-17.7	-18.66	-39.31	Upgrade
EBITDA Margin	-5007.01%	-2952.42%	-722.22%	-505.93%	-1406.02%	-260.93%	-	-	-	-	Upgrade
Depreciation & Amortization	0.17	0.18	0.17	0.15	0.09	0	0.05	0.03	0.04	0.1	Upgrade
EBIT	-39.48	-44.17	-31.33	-17.23	-34.19	-6.58	-30.44	-17.72	-18.7	-39.41	Upgrade
EBIT Margin	-5029.17%	-2964.43%	-726.14%	-510.37%	-1409.81%	-260.93%	-	-	-	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).